BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2571198)

  • 1. Differences among beta-adrenoceptor blocking drugs in modifying platelet aggregation and arachidonic acid liberation under thrombin stimulation.
    Jancinová V; Nosál R
    Thromb Res; 1989 Jun; 54(6):687-98. PubMed ID: 2571198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the relationship between the inhibition of thrombin stimulated aggregation and thromboxane formation in isolated platelets treated with beta-adrenoceptor blocking drugs.
    Nosál R; Jancinová V; Petríková M
    Thromb Res; 1992 Dec; 68(4-5):333-44. PubMed ID: 1363256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic amphiphilic drugs and platelet phospholipase A(2) (cPLA(2)).
    Nosál R; Jancinová V
    Thromb Res; 2002 Feb; 105(4):339-45. PubMed ID: 12031829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological intervention with platelet phospholipase A2.
    Nosal R; Jancinova V
    Bratisl Lek Listy; 2001; 102(10):447-53. PubMed ID: 11802290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of arachidonic acid and its metabolites in the inhibitory effect of beta-adrenoceptor blocking drugs on blood platelets.
    Nosál R; Jancinová V; Petríková M
    Agents Actions Suppl; 1992; 37():47-52. PubMed ID: 1352937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interaction of beta-adrenoceptor blocking drugs with platelet aggregation, calcium displacement and fluidization of the membrane.
    Nosál R; Jancinová V; Ondrias K; Jakubovský J; Balgavý P
    Biochim Biophys Acta; 1985 Dec; 821(2):217-28. PubMed ID: 2865973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in lipid peroxidation of thrombin-stimulated rat platelets treated with beta-adrenoceptor blocking drugs.
    Nosál R; Petríková M; Jancinová V
    J Lipid Mediat; 1993 Oct; 8(2):121-32. PubMed ID: 7903565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of beta-adrenoceptor blocking drugs on 32P incorporation into and arachidonic acid liberation from phospholipids in stimulated rat mast cells.
    Pecivová J; Drábiková K; Nosál R
    Agents Actions; 1989 Apr; 27(1-2):29-32. PubMed ID: 2568743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of adrenergic beta receptor blockers on phospholipid metabolism in mast cells].
    Pecivová J; Drábiková K; Nosál' R
    Bratisl Lek Listy; 1990 May; 91(5):363-8. PubMed ID: 1974476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of prostaglandins in the effect of beta-blockers on stimulated blood platelets].
    Nosál' R; Jancinová V; Petríková M
    Vnitr Lek; 1991 Mar; 37(3):261-7. PubMed ID: 1674390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of intracellular calcium in A-23187 stimulated and beta-adrenoceptor blocking drug treated blood platelets.
    Nosál R; Jancinová V; Petríková M
    Biochem Pharmacol; 1994 Jun; 47(12):2207-11. PubMed ID: 7913320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of beta-adrenoceptor blocking drugs on histamine liberation, prostaglandin synthesis and phospholipid turnover in isolated mast cells stimulated with concanavalin A.
    Drábiková K; Pecivová J; Petríková M; Jancinová V; Nosál R
    Agents Actions; 1990 Apr; 30(1-2):77-80. PubMed ID: 1695467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiaggregatory Properties of Beta-adrenoceptor Blocking Drugs are Related to their Physico-chemical Properties.
    Nosál R; Jancinová V; Petriková M
    Platelets; 1992; 3(1):29-33. PubMed ID: 21043897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of beta adrenoceptor blocking drugs on the integrity of rat platelets as measured by 51Cr liberation.
    Turcáni P; Nosál R
    Thromb Res; 1981 Jul 1-15; 23(1-2):187-91. PubMed ID: 6117953
    [No Abstract]   [Full Text] [Related]  

  • 15. Incorporation of 3H-arachidonic acid into platelet phospholipids of patients with schizophrenia.
    Yao JK; van Kammen DP
    Prostaglandins Leukot Essent Fatty Acids; 1996 Aug; 55(1-2):21-6. PubMed ID: 8888119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective release of archidonic acid from the phospholipids of human platelets in response to thrombin.
    Bills TK; Smith JB; Silver MJ
    J Clin Invest; 1977 Jul; 60(1):1-6. PubMed ID: 874074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathways of arachidonic acid liberation in thrombin and calcium ionophore A23187-stimulated human endothelial cells: respective roles of phospholipids and triacylglycerol and evidence for diacylglycerol generation from phosphatidylcholine.
    Ragab-Thomas JM; Hullin F; Chap H; Douste-Blazy L
    Biochim Biophys Acta; 1987 Feb; 917(3):388-97. PubMed ID: 3099849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential hydrolysis of phospholipid molecular species during activation of human platelets with thrombin and collagen.
    Takamura H; Narita H; Park HJ; Tanaka K; Matsuura T; Kito M
    J Biol Chem; 1987 Feb; 262(5):2262-9. PubMed ID: 3102469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of 8-bromo cyclic GMP on an extracellular Ca2+-dependent arachidonic acid liberation in collagen-stimulated rabbit platelets.
    Matsuoka I; Nakahata N; Nakanishi H
    Biochem Pharmacol; 1989 Jun; 38(11):1841-7. PubMed ID: 2544181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvedilol--a beta-blocker with considerable antiaggregatory effect on human blood platelets.
    Petrikova M; Jancinova V; Nosal R; Majekova M; Fabryova V
    Bratisl Lek Listy; 2005; 106(1):20-5. PubMed ID: 15869009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.